Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Sarcoma 9Rhabdomyosarcoma 9Sarcoma, Ewing 2Rhabdomyosarcoma, Embryonal 2Rhabdomyosarcoma, Alveolar 2Pancreatic Neoplasms 2Neuroblastoma 2Breast Neoplasms 2Small Cell Lung Carcinoma 1Prostatic Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Osteosarcoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms, Connective and Soft Tissue 1Medulloblastoma 1Malignant mesenchymal tumor 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Leukemia, Myeloid, Acute 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Hodgkin Disease 1Fibrosarcoma 1

Interventions

Filgrastim 10Temozolomide 5Peripheral Blood Stem Cell Transplantation 5sargramostim 4Carboplatin 4Thiotepa 3Cyclophosphamide 3Busulfan 3Topotecan 2Radiotherapy 2Oxaliplatin 2Melphalan 2Irinotecan 2Ifosfamide 2Granulocyte Colony-Stimulating Factor 2Etoposide 2Cyproheptadine 2Cisplatin 2trioctyl phosphine oxide 1palbociclib 1olaparib 1ixabepilone 1ispinesib 1gallium Ga 68 dotatate 1exatecan 1etoposide phosphate 1becatecarin 1alvocidib 1aldesleukin 1Vorinostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Familial ependymoma × Vinorelbine × Sarcoma × Clear all
NCT00003234 2014-07-28

Vinorelbine in Treating Children With Recurrent or Refractory Cancers

Children's Oncology Group

Phase 2 Completed
50 enrolled
CNSSarcoma

Familial ependymoma, Astrocytoma, Neuroblastoma, Sarcoma, Central Nervous System Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡